WAIVER AND FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • November 12th, 2019 • Akebia Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This WAIVER AND FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Agreement”) is entered into as of this 31st day of July, 2019, by and between Silicon Valley Bank (“Bank”) and KERYX BIOPHARMACEUTICALS, INC., a Delaware corporation (“Borrower”).
SUBLEASESublease • November 12th, 2019 • Akebia Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This instrument is a Sublease (this “Sublease”) dated as of September 9, 2019 between KERYX BIOPHARMACEUTICALS, INC., a Delaware corporation (“Sublessor”), and FOUNDATION MEDICINE, INC., a Delaware corporation (“Sublessee”).
SECURITY AGREEMENTSecurity Agreement • November 12th, 2019 • Akebia Therapeutics, Inc. • Pharmaceutical preparations
This SECURITY AGREEMENT (this “Agreement”) is entered into as of August 7, 2019, by and between SILICON VALLEY BANK, a California corporation, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at 275 Grove Street, Suite 2-200, Newton, Massachusetts 02466 (“Bank”) and AKEBIA THERAPEUTICS, INC., a Delaware corporation (“Debtor”), with an office located at 245 First Street, Suite 1400, Cambridge, Massachusetts 02142.
UNCONDITIONAL GUARANTYUnconditional Guaranty • November 12th, 2019 • Akebia Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This continuing Unconditional Guaranty (“Guaranty”) is entered into as of August 7, 2019, by AKEBIA THERAPEUTICS, INC. (“Guarantor”), in favor of Silicon Valley Bank (“Bank”).
